Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,540.00    9.00 (0.59%)
Bid:
1,535.00
Ask:
1,536.00
Spread: 1.00 (0.065%)
Market Cap: £3.24b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Director/PDMR Shareholding

17 May 2023 09:56

RNS Number : 7335Z
Hikma Pharmaceuticals Plc
17 May 2023
Β 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Executive Chairman and CEO

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

Β 

Grant of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour Jordan Kuwait Bank. Darhold Limited is defined as a Person Closely Associated with the Executive Chairman and CEO, who is a director and shareholder of Darhold.

c)

Price(s) and volume(s)

Price(s): Β£0.00p

Volume(s): 1,000,000

d)

Aggregated information

Aggregated volume: 1,000,000

Price: Β£0.00p

e)

Date of the transaction

16 May 2023

f)

Place of the transaction

Amman

Β 

Β 

Β 

Β 

Mazen Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

Β 

Grant of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour Jordan Kuwait Bank. Darhold Limited is defined as a Person Closely Associated with the Executive Vice Chairman, who is a director and shareholder of Darhold.

c)

Price(s) and volume(s)

Price(s): Β£0.00p

Volume(s): 1,000,000

d)

Aggregated information

Aggregated volume: 1,000,000

Price: Β£0.00p

e)

Date of the transaction

16 May 2023

f)

Place of the transaction

Amman

Β 

Β 

Mohammed 'Ali' Al-Husry

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mohammed 'Ali' Al-Husry

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

Β 

Grant of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour Jordan Kuwait Bank. Darhold Limited is defined as a Person Closely Associated with the Non-Executive Director, who is a director and shareholder of Darhold.

c)

Price(s) and volume(s)

Price(s): Β£0.00p

Volume(s): 1,000,000

d)

Aggregated information

Aggregated volume: 1,000,000

Price: Β£0.00p

e)

Date of the transaction

16 May 2023

f)

Place of the transaction

Amman

Β 

Helen Middlemist

Deputy Company Secretary

17 May 2023

+44 (0) 2073992760

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHGIGDULUBDGXR
Date   Source Headline
18th Nov 20094:37 pmRNSDirector/PDMR Shareholding
18th Nov 20094:29 pmRNSDirector/PDMR Shareholding
12th Nov 20097:00 amRNSInterim Management Statement
2nd Nov 200912:35 pmRNSTotal Voting Rights
20th Oct 200912:21 pmRNSBlocklisting Interim Review
16th Oct 200912:30 pmRNSDirector/PDMR Shareholding
1st Oct 200910:10 amRNSAdditional Listing
1st Oct 200910:04 amRNSTotal Voting Rights
27th Aug 20097:00 amRNSHalf Yearly Report
5th Aug 200911:51 amRNSTotal Voting Rights
17th Jul 20097:00 amRNSHikma signs licensing agreement
29th Jun 200911:58 amRNSDirector/PDMR Shareholding
19th May 200910:42 amRNSDirector/PDMR Shareholding
14th May 20096:12 pmRNSResult of AGM
14th May 20097:00 amRNSInterim Management Statement
12th May 20095:37 pmRNSAnnual Information Update
11th May 20092:08 pmRNSTotal Voting Rights
11th May 20091:57 pmRNSDirector/PDMR Shareholding
16th Apr 20094:00 pmRNSDirector/PDMR Shareholding
9th Apr 20093:59 pmRNSAnnual Financial Report
19th Mar 20095:02 pmRNSDirector/PDMR Shareholding
18th Mar 20094:39 pmRNSDirector/PDMR Shareholding
17th Mar 20097:00 amRNSFinal Results
26th Jan 200911:14 amRNSHolding(s) in Company
15th Jan 20093:58 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSTrading Statement
2nd Jan 200910:07 amRNSTotal Voting Rights
3rd Dec 20083:10 pmRNSTotal Voting Rights
25th Nov 20087:00 amRNSStatement re Injectables Presentation
5th Nov 20087:00 amRNSInterim Management Statement
3rd Nov 200810:40 amRNSTotal Voting Rights
22nd Oct 20089:42 amRNSBlocklisting Interim Review
17th Oct 20085:26 pmRNSDirector/PDMR Shareholding
13th Oct 20082:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20084:51 pmRNSTotal Voting Rights
15th Sep 20085:21 pmRNSDirector/PDMR Shareholding
2nd Sep 20085:30 pmRNSTotal Voting Rights
28th Aug 20087:00 amRNSInterim Results
6th Aug 20089:25 amRNSTotal Voting Rights
21st Jul 20087:00 amRNSTrading Statement
2nd Jul 200811:53 amRNSTotal Voting Rights
25th Jun 20084:31 pmRNSDirector/PDMR Shareholding
25th Jun 200811:43 amRNSHolding(s) in Company
15th May 20085:18 pmRNSResults of Annual General Mee
15th May 200811:00 amRNSAGM and IMS
15th May 20089:07 amRNSTR-1: Notifications of Major
12th May 20082:37 pmRNSAnnual Information Update
30th Apr 20083:22 pmRNSLTIP Awards
15th Apr 20082:40 pmRNSNotice of Annual Report
31st Mar 20082:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.